Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 72
Filter
1.
Geophys Res Lett ; 48(4): e2020GL091651, 2021 Feb 28.
Article in English | MEDLINE | ID: mdl-33776161

ABSTRACT

Wind-formed features are abundant in Oxia Planum (Mars), the landing site of the 2022 ExoMars mission, which shows geological evidence for a past wet environment. Studies of aeolian bedforms at the landing site were focused on assessing the risk for rover trafficability, however their potential in recording climatic fluctuations has not been explored. Here we show that the landing site experienced multiple climatic changes in the Amazonian, which are recorded by an intriguing set of ridges that we interpret as Periodic Bedrock Ridges (PBRs). Clues for a PBR origin result from ridge regularity, defect terminations, and the presence of preserved megaripples detaching from the PBRs. PBR orientation differs from superimposed transverse aeolian ridges pointing toward a major change in wind regime. Our results provide constrains on PBR formation mechanisms and offer indications on paleo winds that will be crucial for understanding the landing site geology.

2.
Mol Brain ; 11(1): 3, 2018 01 15.
Article in English | MEDLINE | ID: mdl-29334986

ABSTRACT

Multiple sclerosis is characterized by tissue atrophy involving the brain and the spinal cord, where reactive inflammation contributes to the neurodegenerative processes. Recently, the presence of synapse alterations induced by the inflammatory responses was suggested by experimental and clinical observations, in experimental autoimmune encephalomyelitis mouse model and in patients, respectively. Further knowledge on the interplay between pro-inflammatory agents, neuroglia and synaptic dysfunction is crucial to the design of unconventional protective molecules. Here we report the effects, on spinal cord circuits, of a cytokine cocktail that partly mimics the signature of T lymphocytes sub population Th1. In embryonic mouse spinal organ-cultures, containing neuronal cells and neuroglia, cytokines induced inflammatory responses accompanied by a significant increase in spontaneous synaptic activity. We suggest that cytokines specifically altered signal integration in spinal networks by speeding the decay of GABAA responses. This hypothesis is supported by the finding that synapse protection by a non-peptidic NGF mimetic molecule prevented both the changes in the time course of GABA events and in network activity that were left unchanged by the cytokine production from astrocytes and microglia present in the cultured tissue. In conclusion, we developed an important tool for the study of synaptic alterations induced by inflammation, that takes into account the role of neuronal and not neuronal resident cells.


Subject(s)
Implants, Experimental , Inflammation/metabolism , Inflammation/pathology , Signal Transduction , Spinal Cord/pathology , Synaptic Transmission , Animals , Chemokines/metabolism , Female , Gliosis/pathology , Gliosis/physiopathology , Inflammation Mediators/metabolism , MAP Kinase Signaling System/drug effects , Male , Mice, Inbred C57BL , Nerve Growth Factor/pharmacology , Organ Culture Techniques , Receptor, trkA/metabolism , Receptor, trkB/metabolism , Receptors, GABA/metabolism , Signal Transduction/drug effects , Spinal Cord/physiopathology , Stress, Physiological/drug effects , Synapses/drug effects , Synapses/metabolism , Synaptic Transmission/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
3.
Eur J Clin Microbiol Infect Dis ; 34(10): 1999-2007, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26173694

ABSTRACT

Candida spp. usually colonize ulcerative lesions of atrophic mucosa in patients with chemotherapy-induced oral mucositis inducing severe inflammation. The spread of antifungal-resistant strains strongly encouraged the search of complementary or alternative therapeutic strategies to cure inflamed mucosa. In this paper, we studied the effects of a near-infrared (NIR) laser system with dual-wavelength emission (808 nm + 904 nm) on the survival and inflammatory potential of C. albicans, C. glabrata, and C. parapsilosis. Laser treatment was performed with a Multiwave Locked System laser. Survival and apoptosis of fungal strains were evaluated by colony-forming units (CFU) counting and annexin V staining. Cytokine production was evaluated by ImmunoPlex array. Laser treatment significantly affected the survival of Candida spp. by inducing apoptosis and induced a lower production of inflammatory cytokines by dendritic cells compared to untreated fungi. No differences in the survival and inflammatory potential were recorded in treated or untreated Saccharomyces cerevisiae cells, used as the control non-pathogenic microorganism. Laser treatment altered the survival and inflammatory potential of pathogenic Candida spp. These data provide experimental support to the use of NIR laser radiation as a co-adjuvant of antifungal therapy in patients with oral mucositis (OM) complicated by Candida infections.


Subject(s)
Antineoplastic Agents/adverse effects , Candida/radiation effects , Candidiasis/chemically induced , Candidiasis/radiotherapy , Laser Therapy , Stomatitis/chemically induced , Stomatitis/radiotherapy , Apoptosis/radiation effects , Humans , Inflammation/radiotherapy
4.
Cell Death Dis ; 3: e389, 2012 Sep 06.
Article in English | MEDLINE | ID: mdl-22951986

ABSTRACT

Exploitation of the biologic activity of neurotrophins is desirable for medical purposes, but their protein nature intrinsically bears adverse pharmacokinetic properties. Here, we report synthesis and biologic characterization of a novel class of low molecular weight, non-peptidic compounds with NGF (nerve growth factor)-mimetic properties. MT2, a representative compound, bound to Trk (tropomyosin kinase receptor)A chain on NGF-sensitive cells, as well as in cell-free assays, at nanomolar concentrations and induced TrkA autophosphorylation and receptor-mediated internalization. MT2 binding involved at least two amino-acid residues within TrkA molecule. Like NGF, MT2 increased phosphorylation of extracellular signal-regulated kinase 1/2 and Akt proteins and production of MKP-1 phosphatase (dual specificity phosphatase 1), modulated p38 mitogen-activated protein kinase activation,sustained survival of serum-starved PC12 or RDG cells, and promoted their differentiation. However, the intensity of such responses was heterogenous, as the ability of maintaining survival was equally possessed by NGF and MT2, whereas the induction of differentiation was expressed at definitely lower levels by the mimetic. Analysis of TrkA autophosphorylation patterns induced by MT2 revealed a strong tyrosine (Tyr)490 and a limited Tyr785 and Tyr674/675 activation, findings coherent with the observed functional divarication. Consistently, in an NGF-deprived rat hippocampal neuronal model of Alzheimer Disease, MT2 could correct the biochemical abnormalities and sustain cell survival. Thus, NGF mimetics may reveal interesting investigational tools in neurobiology, as well as promising drug candidates.


Subject(s)
Azepines/pharmacology , Nerve Growth Factor/pharmacology , Receptor, trkA/agonists , Animals , Azepines/chemistry , Binding Sites , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Hippocampus/cytology , Hippocampus/metabolism , Humans , Mice , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Molecular Weight , NIH 3T3 Cells , Nerve Growth Factor/genetics , Nerve Growth Factor/metabolism , PC12 Cells , Phosphorylation , Protein Structure, Tertiary , Proto-Oncogene Proteins c-akt/metabolism , Rats , Receptor, trkA/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , p38 Mitogen-Activated Protein Kinases/metabolism
5.
Cell Death Dis ; 3: e339, 2012 07 05.
Article in English | MEDLINE | ID: mdl-22764098

ABSTRACT

Exploitation of the biologic activity of neurotrophins is desirable for medical purposes, but their protein nature intrinsically bears adverse pharmacokinetic properties. Here, we report synthesis and biologic characterization of a novel class of low molecular weight, non-peptidic compounds with NGF (nerve growth factor)-mimetic properties. MT2, a representative compound, bound to Trk (tropomyosin kinase receptor)A chain on NGF-sensitive cells, as well as in cell-free assays, at nanomolar concentrations and induced TrkA autophosphorylation and receptor-mediated internalization. MT2 binding involved at least two amino-acid residues within TrkA molecule. Like NGF, MT2 increased phosphorylation of extracellular signal-regulated kinase1/2 and Akt proteins and production of MKP-1 phosphatase (dual specificity phosphatase 1), modulated p38 mitogen-activated protein kinase activation, sustained survival of serum-starved PC12 or RDG cells, and promoted their differentiation. However, the intensity of such responses was heterogenous, as the ability of maintaining survival was equally possessed by NGF and MT2, whereas the induction of differentiation was expressed at definitely lower levels by the mimetic. Analysis of TrkA autophosphorylation patterns induced by MT2 revealed a strong tyrosine (Tyr)490 and a limited Tyr785 and Tyr674/675 activation, findings coherent with the observed functional divarication. Consistently, in an NGF-deprived rat hippocampal neuronal model of Alzheimer Disease, MT2 could correct the biochemical abnormalities and sustain cell survival. Thus, NGF mimetics may reveal interesting investigational tools in neurobiology, as well as promising drug candidates.


Subject(s)
Azepines/pharmacology , Nerve Growth Factor/pharmacology , Receptor, trkA/agonists , Animals , Azepines/chemistry , Binding Sites , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Hippocampus/cytology , Hippocampus/metabolism , Humans , Mice , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Molecular Weight , NIH 3T3 Cells , Nerve Growth Factor/genetics , Nerve Growth Factor/metabolism , PC12 Cells , Phosphorylation , Protein Structure, Tertiary , Proto-Oncogene Proteins c-akt/metabolism , Rats , Receptor, trkA/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , p38 Mitogen-Activated Protein Kinases/metabolism
7.
J Orthop Traumatol ; 2(3): 129-33, 2002 Jun.
Article in English | MEDLINE | ID: mdl-24604490

ABSTRACT

The purpose of this study was to evaluate the medium-term clinical and radiological outcomes of two metal-backed acetabular cups with metal-on-metal and metal-on-polyethylene joint couples, in patients unselected for age. Seventy-five metal-on-polyethylene CLS expansion cups were implanted in 70 patients and 66 metal-on-metal Fitek cups were implanted in 65 patients. The average age at surgery in the two groups was 63 years (range, 25 to 72 years) and 58 years (range, 32 to 68 years), respectively. Data regarding 64 of 75 CLS cups (85%) and 58 of 66 Fitek cups (88%) were collected at a minimum 36-month and maximum 144-month follow-up. The Harris hip score showed excellent results in 86% of the CLS cups, good results in 7%, and fair results in 7%. No poor results were recorded. For metal-on-metal acetabular components, excellent results were recorded in 84% of the cups, good results in 8%, fair results in 5%, and poor results in 3%. Fifty-five patients with 57 of 64 CLS cups (89%) and 50 patients with 51 of 58 Fitek cups (88%) were fully satisfied with their prosthesis. No acetabular reconstructions were revised for aseptic loosening. No radiolucent lines greater than 2 mm were observed, either about CLS or Fitek cups, and low incidence of osteolysis and polyethylene wear was noted in metal-on-polyethylene articulations. Post-operative three-phase bone scanning was obtained in 51 patients and this examination did not show increased uptake in blood pool or bone phase indicating aseptic loosening of CLS and Fitek cups. In conclusion, we found similar rates of excellent and good results using two acetabular components with different bearing surfaces, in patients of unselected age. Therefore, the less expensive implant should be selected for total hip arthroplasty in elderly or low-demand patients.

8.
Diabetologia ; 44(10): 1281-95, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11692177

ABSTRACT

AIMS/HYPOTHESIS: Using primary cultures of human pancreatic islets, purified human pancreatic beta cells and the mouse beta TC6-F7 cell line, we analysed the expression of nerve growth factor, (NGF/NGF) receptors in beta cells. To investigate whether NGF could sub-serve an autocrine antiapoptotic role in beta cells, we studied the effects of NGF withdrawal using a neutralizing monoclonal anti-NGF antibody. METHODS: The expression of NGF and NGF receptors (gp140(Trk-A) and p75(NTR)) were analysed by RT-PCR and immunofluorescence. Pulse-chase experiments and beta cell/PC12 co-cultures were used to investigate NGF production and secretion from beta cells. Possible apoptosis induced by NGF withdrawal was monitored by phosphatidylserine translocation, nucleosomal formation, DNA laddering and FACS analysis. Involvement of transcription/translation mechanisms were investigated as well as the gp140(Trk-A) required. Finally, signal transduction pathways typically involved in apoptotic mechanisms were analysed by western blot analysis. RESULTS: We show that NGF and both NGF receptors, gp140(Trk-A) and p75(NTR) are expressed in beta cells where NGF is produced and secreted in a biologically active form. NGF-withdrawal induces beta-cell transcription/translation independent apoptosis but mediated by gp140(Trk-A). Analysis of signal transduction pathways revealed that NGF withdrawal inhibits the PI3-K, protein kinase B (AKT), Bad survival pathway and activates c-Jun kinase (JNK) whereas ERKs and p38 mitogen-activated protein kinase (MAPK) are not affected. Moreover, Bcl-XL, but not Bcl-2 protein expression are reduced. CONCLUSION/INTERPRETATION: We suggest that the integrity of the NGF/NGF receptor system and NGF bioavailability participate in controlling beta-cell survival in culture which represents a key issue for improving possibilities for transplantations in the treatment of diabetes.


Subject(s)
Apoptosis , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , JNK Mitogen-Activated Protein Kinases , Nerve Growth Factor/physiology , Protein Serine-Threonine Kinases , Animals , Antibodies, Monoclonal/pharmacology , Carrier Proteins/metabolism , Cell Line , Cells, Cultured , Coculture Techniques , DNA Fragmentation , Enzyme Activation , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression , Humans , MAP Kinase Kinase 4 , Male , Mice , Mice, Transgenic , Middle Aged , Mitogen-Activated Protein Kinase Kinases/metabolism , Nerve Growth Factor/genetics , Nerve Growth Factor/immunology , Nucleosomes/ultrastructure , PC12 Cells , Phosphatidylinositol 3-Kinases/metabolism , Phosphatidylserines/metabolism , Phosphorylation , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger/analysis , Rats , Receptor, Nerve Growth Factor , Receptor, trkA/analysis , Receptor, trkA/genetics , Receptors, Nerve Growth Factor/analysis , Receptors, Nerve Growth Factor/genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , bcl-Associated Death Protein , bcl-X Protein
9.
J Biol Chem ; 276(42): 39027-36, 2001 Oct 19.
Article in English | MEDLINE | ID: mdl-11495898

ABSTRACT

Survival of memory B lymphocytes is tightly linked to the integrity of the Bcl-2 protein and is regulated by a nerve growth factor (NGF) autocrine circuit. In factor-starved memory B cells, the addition of exogenous NGF promptly induced p38 mitogen-activated protein kinase (MAPK), but not c-Jun N-terminal kinase (JNK), dephosphorylation. Conversely, withdrawal of endogenous NGF was followed by p38 MAPK activation and translocation onto mitochondria, whereby it combined with and phosphorylated Bcl-2, as assessed by co-immunoprecipitation and kinase assays in vivo and in vitro. Mitochondria isolated from human memory B cells, then exposed to recombinant p38 MAPK, released cytochrome c, as did mitochondria from Bcl-2-negative MDCK cells loaded with recombinant Bcl-2. Apoptosis induced by NGF neutralization could be blocked by the specific p38 MAPK inhibitor SB203580 or by Bcl-2 mutations in Ser-87 or Thr-56. These data demonstrate that the molecular mechanisms underlying the survival factor function of NGF critically rely upon the continuous inactivation of p38 MAPK, a Bcl-2-modifying enzyme.


Subject(s)
Apoptosis , B-Lymphocytes/pathology , Cytochrome c Group/metabolism , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Nerve Growth Factor/metabolism , Nerve Growth Factor/physiology , Proto-Oncogene Proteins c-bcl-2/metabolism , Animals , Cell Nucleus/metabolism , Cells, Cultured , Cytosol/metabolism , DNA Fragmentation , Enzyme Inhibitors/pharmacology , Humans , Imidazoles/pharmacology , Immunologic Memory , MAP Kinase Kinase 4 , Microscopy, Fluorescence , Mitochondria/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Phosphorylation , Precipitin Tests , Protein Binding , Protein Transport , Pyridines/pharmacology , Rats , Recombinant Proteins/metabolism , Serine/chemistry , Threonine/chemistry , Time Factors , p38 Mitogen-Activated Protein Kinases
10.
Biochem Biophys Res Commun ; 278(3): 753-9, 2000 Nov 30.
Article in English | MEDLINE | ID: mdl-11095980

ABSTRACT

The sIgG(+) lymphoblastoid B cell line CESS spontaneously produces a high amount of NGF and expresses both high affinity (p140(Trk-A)) and low affinity (p75(NTR)) NGF receptors. Blocking NGF signals with neutralizing antibodies or specific Trk-A inhibitors induces a rapid phosphorylation of antiapoptotic Bcl-2 protein, followed by caspase activation, and apoptotic death of CESS cells. Bcl-2 phosphorylation in several sites within a approximately 60 aa "loop" domain of protein is known to regulate its antiapoptotic function. Accordingly, CESS cells expressing the loop deletional mutant cDNA constructs Bcl-2 Delta40-91 were completely resistant to apoptosis induced by NGF withdrawal, indicating that Bcl-2 phosphorylation is a critical event. NGF withdrawal induces p38 MAPK, but not JNK, activation in CESS cells, and SB203580, a specific inhibitor of p38 MAPK, is able to prevent both Bcl-2 phosphorylation and apoptosis, indicating that p38 MAPK is the enzyme responsible for these events.


Subject(s)
Apoptosis/drug effects , Mitogen-Activated Protein Kinases/metabolism , Nerve Growth Factor/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Apoptosis/physiology , B-Lymphocytes , Carbazoles/pharmacology , Cell Division/drug effects , Enzyme Activation , Enzyme Inhibitors/pharmacology , Genes, bcl-2 , Humans , Indole Alkaloids , JNK Mitogen-Activated Protein Kinases , Kinetics , Phosphorylation , Receptor, trkA/genetics , Receptor, trkA/physiology , Receptors, Nerve Growth Factor/genetics , Receptors, Nerve Growth Factor/physiology , Sequence Deletion , Signal Transduction/drug effects , Signal Transduction/physiology , Tumor Cells, Cultured , Tyrphostins/pharmacology , p38 Mitogen-Activated Protein Kinases
11.
Minerva Stomatol ; 48(6): 277-82, 1999 Jun.
Article in English, Italian | MEDLINE | ID: mdl-10522397

ABSTRACT

Erythema multiforme (EM) is an acute inflammatory disease with an autoimmune pathogenesis clinically expressing in a wide variety of mucocutaneous illnesses. It is usually described in a minor form (Von Hebra) characterized by classical cutaneous lesions, and in major form (Stevens-Johnson), involving mucosal damage, while a clinical type restricted to the oral mucosa is described in oral pathology. A considerable number of factors of different nature have been reported as etiologic agents of EM, but most of them are not well documented; however, a certain relationship with EM is recognized for different classes of systemic drugs. This paper describes a case of Stevens-Johnson syndrome with initial oral involvement, in which the precipitating factor was due to the administration of systemic glucocorticoids, prescribed for the therapeutic treatment of an erosive form of oral lichen planus.


Subject(s)
Glucocorticoids/therapeutic use , Lichen Planus/drug therapy , Stevens-Johnson Syndrome/chemically induced , Aged , Aged, 80 and over , Female , Fluorescent Antibody Technique , Glucocorticoids/adverse effects , Humans , Lichen Planus/complications , Oral Ulcer/etiology , Oral Ulcer/pathology , Stevens-Johnson Syndrome/complications , Stevens-Johnson Syndrome/pathology
12.
Biochem Biophys Res Commun ; 262(3): 838-44, 1999 Sep 07.
Article in English | MEDLINE | ID: mdl-10471412

ABSTRACT

The molecular mechanisms underlying the growth inhibition induced by interferon-alpha (IFN-alpha) in B16 murine melanoma cells were investigated. IFN-alpha did not induce cell apoptosis, but strongly interfered with the synthesis of basic fibroblast growth factor (bFGF), which acts as an autocrine growth factor in this system. Inhibition of bFGF synthesis was observed at the same concentrations (50-500 pM, 10-100 U/ml) of IFN-alpha able to induce growth arrest of B16 melanoma cells. Although the synthesis of acidic (a)FGF was only slightly affected by IFN-alpha, the cytokine induced release of an aFGF-related low-molecular-weight peptide, which was able to interfere with bFGF binding to surface receptors. Thus, the molecular mechanisms of IFN-alpha activity on melanoma cells include a specific modulation of the bFGF autocrine circuit.


Subject(s)
Cell Division/drug effects , Fibroblast Growth Factor 2/physiology , Interferon-alpha/pharmacology , Animals , Cysteine/metabolism , Fibroblast Growth Factor 1/physiology , Fibroblast Growth Factor 2/biosynthesis , Fibroblast Growth Factor 2/genetics , Gene Expression Regulation, Neoplastic , Humans , Kinetics , Melanoma, Experimental , Methionine/metabolism , Mice , RNA, Messenger/genetics , Recombinant Proteins/metabolism , Transcription, Genetic , Tumor Cells, Cultured
13.
Minerva Stomatol ; 48(4): 151-9, 1999 Apr.
Article in English, Italian | MEDLINE | ID: mdl-10431536

ABSTRACT

Oral Lichen Planus is a chronic inflammatory pathology with not well defined etiology, characterized by an immunoreactivity directed against the keratinocytes of basal layer and mediated by a cellular infiltrate of T-lymphocytes. This immunoreactivity is caused by a modification of basal keratinocytes surface antigens, with activation of antigen-presenting cells allowing the recognition on non-self antigens by CD4 lymphocytes. The migration of T-cells at the sites of the damage and their interactions with leucocytes and keratinocytes represent a key effect of pathogenesis of OLP, and are mediated by specific cell surface adhesion molecules. Recent studies in molecular biology, with the discovery and the definition of cell adhesion receptors, have greatly contributed to clarify the pathogenic mechanism of OLP; these molecules regulate immune functions such as adhesion to endothelial cells, lymphocytes migration into extravasal tissues at the site of immune response and T-cell interactions with target cell antigens. The adhesion molecules have been classified into various families, differing on the basis of their molecular structure: the Immunoglobulin Superfamily (ICAM 1-3, PECAM-1, VCAM-1), the Selectins (ELAM-1, LECAM-1, GMP-140), the Integrins (LEA-1) and others. In this paper, the principal classes of adhesion molecules which are involved in the immune response are described and their importance in the pathogenesis of Lichen Planus is underlined.


Subject(s)
Lichen Planus, Oral/etiology , Cell Adhesion Molecules , Endothelium, Vascular/pathology , Humans , Lichen Planus, Oral/pathology , Neutrophils
14.
Boll Chim Farm ; 137(11): 443-7, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10077878

ABSTRACT

JUSTIFICATION: Lipid oxidation is one of the major changes that can occur during processing, distribution, storage and final preparation of foods. The oxidation could be prevented by adding synthetic or natural antioxidants in spite of safety of synthetic ones has been questioned. This situation promotes increasing demand for food additives of natural origin. OBJECTIVE: The objective of this study was to evaluate the antioxidant activity of cinnamon extracts. METHODS: Cinnamon samples were obtained at local market, milled (32 mesh sieve) and submitted to sequential extraction using as solvents: ether, methanol and water. The antioxidant activity in the extracts was measured by the b-carotene/linoleic acid system, at 50 degrees C and absorbances reading at 470 nm every 15 min intervals for 120 min. Two controls were used in this determination: one with synthetic antioxidant (BHT, 100 ppm) and other without antioxidant. The water extract was fraccionated using silica Gel 60 and 60G and through chromatographic processes: thin layer, (T.L.C.) and column, using BAW as mobile phase and ethylacetate, petroleum ether, methanol and water as eluent, respectively. RESULTS: The etheric (0.69 mg), methanolic (0.88 mg) and aqueous (0.44 mg) cinnamon extracts, inhibited the oxidative process in 68%; 95.5% and 87.5% respectively. The BHT control inhibited 80% oxidation. The spray reagents (1) beta-carotene/linoleic acid and (2) Fe Cl3/K3 Fe (CN)4 1% sol, showed spots in T.L.C. with antioxidant activity (1) and blue color (2), indicating the presence of phenolic compounds with Rf values of 0.50. Five fractions were obtained by column partition with antioxidant activity and the presence of phenolic compounds. SIGNIFICANCE: These results suggest that the cinnamon extracts can be used as food antioxidant together with the improvement of food palatability. Further studies are in processing of analysing the sinergic association of extracts with synthetic antioxidant and to identify compounds with antioxidant activity in cinnamon extracts.


Subject(s)
Antioxidants/pharmacology , Cinnamomum zeylanicum/analysis , Food Analysis , Plant Extracts/pharmacology
15.
Exp Hematol ; 24(8): 868-74, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8690044

ABSTRACT

We have studied the effects of several interleukin-1 (IL-1) inhibitors--IL-1 receptor antagonist (IL-1ra), soluble IL-1 receptor (sIL-1R) types I and II, and neutralizing monoclonal antibody (mAb) specific for IL-1 receptor type I--on the osteoclast-activating factor (OAF) activity of recombinant IL-1beta and of culture supernatants of unfractionated bone marrow mononuclear cells from multiple myeloma (MM) patients. The latter activity sharply correlated with the IL-1 content of culture supernatants (r = 0.949; p < 0.001). IL-1ra and sIL-1R types I and II had a clear-cut modulating effect on the OAF activity of IL-1beta at saturating doses (2-10 ng/mL); their effect was evident at 2 ng/mL and was dose-dependent over a large range of concentrations. Similarly, the three reagents neutralized the OAF activities of all MM cell supernatants in a dose-dependent fashion and completely abolished them when tested at the fixed concentration of 5 nM. The bone-resorbing activity of tumor necrosis factor-alpha (TNF-alpha) or lymphotoxin (LT), tested alone or added to MM cell supernatants, was affected not at all by IL-1ra and only minimally by sIL-1R types I and II, suggesting that little or no endogenous IL-1 was produced by the rat cells in the assay under TNF-alpha or LT stimulation. Consistent with these findings, PGE2 production elicited by IL-1beta or IL-1-rich supernatants in the rat long-bone assay was abolished by each reagent. Also, mAbs to the IL-1R p80 (type I) chains could modulate the effects of IL-1--recombinant or plasma cell-derived--in the OAF assay, but their activity was markedly less pronounced when compared with the IL-1 inhibitors, since they could never completely abolish bone resorption. Taken together, these findings demonstrate that inhibition of IL-1 interaction with cognate surface receptors on bone cells effectively counteracts its biologic activity. The findings also strongly indicate that OAF activity in conditioned medium of unfractionated myeloma bone marrow cells is predominantly, if not solely, related to IL-1beta.


Subject(s)
Bone Marrow/pathology , Interleukin-1/antagonists & inhibitors , Interleukin-1/physiology , Lymphokines/physiology , Multiple Myeloma/pathology , Osteoclasts/physiology , Sialoglycoproteins/pharmacology , Animals , Antibodies, Monoclonal , Bone Marrow/drug effects , Bone Marrow Cells , Bone Resorption , Calcium/metabolism , Cell Division/drug effects , Cells, Cultured , Humans , Interleukin 1 Receptor Antagonist Protein , Interleukin-1/pharmacology , Lymphokines/immunology , Lymphotoxin-alpha/pharmacology , Neoplasm Staging , Osteoclasts/drug effects , Rats , Recombinant Proteins/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
16.
Cell ; 85(3): 345-56, 1996 May 03.
Article in English | MEDLINE | ID: mdl-8616890

ABSTRACT

Production of nerve growth factor (NGF) was assessed in cultures of human T and B lymphocytes and macrophages. NGF was constitutively produced by B cells only, which also expressed surface p140trk-A and p75NGFR molecules and hence efficiently bound and internalized the cytokine. Neutralization of endogenous NGF caused disappearance of Bcl-2 protein and apoptotic death of resting lymphocytes bearing surface IgG or IgA, a population comprising memory cells, while surface IgM/IgD "virgin" B lymphocytes were not affected. In vivo administration of neutralizing anti-NGF antibodies caused strong reduction in the titer of specific IgG in mice immunized with tetanus toxoid, nitrophenol, or arsonate and reduced numbers of surface IgG or IgA B lymphocytes. Thus, NGF is an autocrine survival factor for memory B lymphocytes.


Subject(s)
B-Lymphocyte Subsets/metabolism , Immunologic Memory/immunology , Nerve Growth Factors/biosynthesis , Animals , Antibody Specificity , B-Lymphocyte Subsets/chemistry , B-Lymphocyte Subsets/cytology , Cell Survival/immunology , Cells, Cultured/chemistry , Cells, Cultured/cytology , Cells, Cultured/metabolism , Female , Humans , Immunophenotyping , Mice , Mice, Inbred BALB C , Nerve Growth Factors/immunology , Nerve Growth Factors/metabolism , Neutralization Tests , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/physiology , Receptor Protein-Tyrosine Kinases/biosynthesis , Receptor Protein-Tyrosine Kinases/physiology , Receptor, trkA , Receptors, Cell Surface/analysis , Receptors, Nerve Growth Factor/biosynthesis , Receptors, Nerve Growth Factor/physiology
17.
Haematologica ; 81(2): 105-9, 1996.
Article in English | MEDLINE | ID: mdl-8641636

ABSTRACT

BACKGROUND AND METHODS: Familial occurrence of immunoglobulin-related (AL) amyloidosis has occasionally been reported. In this work we describe the concomitance of systemic amyloidosis and monoclonal gammopathy (one case of Waldenström's macroglobulinemia and two cases without multiple myeloma or related diseases) in three Italian siblings, two males and one female. RESULTS AND CONCLUSIONS: All of them showed a common pattern of polyneuropathy to different degrees; two presented a sicca syndrome and one also suffered from nephropathy. Two of them showed the same HLA typing with the same light chain type (k), but had different presenting symptoms. Polyneuropathy and a history of peptic disease in two cases was suggestive of type III familial amyloidotic polyneuropathy (FAP) occurring in the setting of a familial monoclonal component. However, immunohistochemical studies on different tissue specimens using anti-apolipoprotein A1 and anti-transthyretin antibodies were negative. Further screening of DNA samples for transthyretin (TTR) gene mutations was also negative. Clinical and laboratory investigations ruled out reactive or senile amyloidosis and immunohistochemical studies with anti-light chain antibodies on amyloidotic tissue specimens were positive. As a consequence, this family represents a new case of familial AL-amyloidosis.


Subject(s)
Amyloidosis/genetics , Paraproteinemias/genetics , Aged , Amyloidosis/immunology , Female , Humans , Italy , Male , Middle Aged , Pedigree
18.
Leukemia ; 7 Suppl 2: S10-2, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8361209

ABSTRACT

In Acute Myelogenous Leukemia (AML), Interleukin 1 (IL-1) might sustain autocrine and paracrine loops of leukemic growth. An IL-1 inhibitor has been recently purified and cloned. This molecule binds to the IL-1 receptors but has no IL-1 like activity fulfilling the characteristics of a pure Interleukin-1 receptor antagonist (IL-1ra). We studied the in vitro effect of human recombinant IL-1ra on proliferation of AML blasts. Spontaneous as well as IL-1 stimulated AML proliferation was significantly inhibited by the addition of 50 ng/ml of recombinant IL-1ra in a dose dependent manner. The inhibitory effect of IL-1ra was measurable after 12 hours of culture and reached a plateau at 60 hrs. We found that IL-1ra could compete with IL-1 in binding to specific IL-1 receptors on AML cells. As expected, culture supernatants of unstimulated leukemic samples contained IL-1 beta and GM-CSF activity. The incubation of the same leukemic blasts with IL-1 ra was followed by reduction or disappearance of GM-CSF in culture supernatants whereas the IL-1 beta production was only partially modulated. By Northern blot experiments performed on freshly isolated, uncultured leukemic blasts, we found a constitutive expression of the IL-1 beta gene in 19 of 23 AML cases analyzed. On the contrary, only three of these patients express the IL-1 RA mRNA. All together these results suggest that imbalanced secretion of IL-1 and its natural receptor antagonist could contribute to the unrestricted growth of AML cells.


Subject(s)
Leukemia, Myeloid, Acute/pathology , Sialoglycoproteins/pharmacology , Cell Division/drug effects , Cell Division/physiology , Cytokines/metabolism , Dose-Response Relationship, Drug , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Interleukin 1 Receptor Antagonist Protein , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/metabolism , Sialoglycoproteins/genetics , Tumor Cells, Cultured
19.
J Clin Invest ; 91(6): 2504-12, 1993 Jun.
Article in English | MEDLINE | ID: mdl-7685771

ABSTRACT

To elucidate mechanisms underlying neovascularization that accompanies certain chronic immune/inflammatory disorders, the effects of interferon-alpha (IFN-alpha) and interleukin 2 (IL-2) on endothelial cell (EC) growth in vitro and angiogenesis in vivo were studied. Preincubation of cultured human ECs with IFN-alpha, followed by exposure to IL-2, resulted in effective stimulation of cell growth, whereas either cytokine alone had only a slight effect. The combination of IFN-alpha/IL-2 induced an angiogenic response in the rabbit cornea. IL-2 receptor expression was enhanced on IFN-alpha-treated ECs: p55 was increased and p70 was induced. 125I-IL-2 binding to ECs treated with IFN-alpha was enhanced (Kd from approximately 7 nM to approximately 260 pM with IFN-alpha), and anti-p55 IgG blocked 125I-IL-2/EC interaction as well as IL-2-mediated EC proliferation. Consistent with these findings in cell culture, immunohistologic studies demonstrated p55 and p70 antigen in the vasculature of rheumatoid joints, but not in normal joint tissue. Exposure of cultured ECs to IFN-alpha increased levels of intracellular EC basic fibroblast growth factor (bFGF), and subsequent addition of IL-2 led to bFGF release into the medium. The observation that anti-bFGF IgG largely blocked EC proliferation in response to IFN-alpha/IL-2 suggested that bFGF was a critical agent in this setting. These data suggest a mechanism rendering ECs responsive to IL-2 which may be relevant in immune/inflammatory disorders: IFN-alpha-mediated induction of functional EC receptors for IL-2, which drives cell proliferation by a mechanism dependent on increased synthesis and release of bFGF.


Subject(s)
Endothelium, Vascular/drug effects , Fibroblast Growth Factor 2/biosynthesis , Interferon-alpha/pharmacology , Interleukin-2/pharmacology , Neovascularization, Pathologic , Animals , Arthritis, Rheumatoid/pathology , Cell Division , Cells, Cultured , Cornea/blood supply , Drug Synergism , Endothelium, Vascular/growth & development , Fibroblast Growth Factor 2/pharmacology , Humans , Joints/pathology , Rabbits , Receptors, Interleukin-2/metabolism , Umbilical Veins/cytology
20.
Cytokine ; 5(2): 117-24, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8334227

ABSTRACT

In view of the key role played by interleukin 1 (IL-1) beta in inflammation, its production is likely to be precisely regulated. Previous studies have shown that IL-1 beta biosynthesis is controlled at the transcriptional and translational levels. We have investigated whether post-translational events also play a role in regulating the production of bioactive IL-1 beta. IL-1 beta, which lacks a signal sequence, is released by activated monocytes through a novel pathway of secretion, alternative to the classical endoplasmic reticulum-Golgi route. Secretion of mature 17 kDA IL-1 beta is increased when pulse-labelled activated monocytes are chased in the presence of heat-aggregated immunoglobulins or of various drugs. Febrile temperatures inhibit secretion of mature IL-1 beta, but only reduce its synthesis: treatment with cycloheximide restores secretion. Processing of the 33 kDa precursor to the 17 kDa mature molecule is inhibited when the external pH is 8 or higher: under these conditions, release of unprocessed, biologically inactive 33 kDa IL-1 beta is observed. Thus, secretion of IL-1 beta is regulated by post-translational mechanisms which operate at the level of both proteolytic processing and extracellular export.


Subject(s)
Interleukin-1/metabolism , Monocytes/metabolism , Protein Precursors/metabolism , Protein Processing, Post-Translational , Biological Transport , Cycloheximide/pharmacology , Humans , Hydrogen-Ion Concentration , Immunoglobulin G , L-Lactate Dehydrogenase/analysis , Molecular Weight , Monocytes/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...